This page has been archived on the Web
Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.
NETSPOT: Out of Specification
Last updated
Summary
Product
NETSPOT
Issue
Health products - Product quality
What to do
See instructions below.
Affected products
| Brand | Product Name | Market Authorization | Dosage Form | Strength | Lot |
|---|---|---|---|---|---|
| NETSPOT | NETSPOT | DIN 02490005 | Powder For Solution, Kit | OXODOTREOTIDE 40 MCG / VIAL (kit for the preparation of Gallium (Ga68) Dotatate injection). | PG19CA21001, PG19CA21002 |
Issue
The Vial 1 assay may be out of specification in the affected lot(s).
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of Recall: Radiopharmacy provider
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs - Radiopharmaceuticals
Companies
Advanced Accelerator Applications USA, Inc. 57 E. Willow Street, Millburn New Jersey, United States 07041
Published by
Health Canada
Audience
General public
Healthcare
Industry
Recall class
Type III
Identification number
RA-64016
Get notified
Receive notifications for new and updated recalls and alerts by category.